Onderneming Nextage Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Aandelen
NXTG
IL0004330119
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12-08-20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10-07-22 |
General Counsel | 53 | 12-08-20 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 01-01-94 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12-08-20 |
Israel Makov
CHM | Chairman | 85 | 21-11-11 |
Ron Grupel
BRD | Director/Board Member | 73 | 13-10-14 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 12-08-20 |
Orna Dreazen
BRD | Director/Board Member | 69 | 12-08-20 |
Director/Board Member | 59 | 12-08-20 | |
Director/Board Member | 72 | 12-08-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 33 268 639 | 5 155 250 ( 15,50 %) | 0 | 15,50 % |
Bedrijfsgegevens
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.il![Adres Nextage Therapeutics Ltd(NXTG)](https://cdn.zonebourse.com/static/address/120960937.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-39,80% | 7,63 mld. | |
+8,84% | 3,61 mld. | |
+0,31% | 2,36 mld. | |
-24,56% | 1,86 mld. | |
-18,18% | 1,74 mld. | |
+3,89% | 913 mln. | |
+18,17% | 763 mln. | |
-10,48% | 678 mln. | |
-0,60% | 290 mln. |